Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exceptional Responders Pilot Study: Molecular Profiling of Tumors From Cancer Patients Who Are Exceptional Responders

NCT02243592 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02243592
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02243592 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exceptional Responders Pilot Study: Molecular Profiling of Tumors From Cancer Patients Who Are Exceptional Responders
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Active, not recruiting
Start date
September 24, 2014
Completion date
April 30, 2027
Enrollment
170 (actual)
Sites
73

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm